94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
ORIGINAL RESEARCH article
Front. Oncol.
Sec. Hematologic Malignancies
Volume 14 - 2024 | doi: 10.3389/fonc.2024.1434709
Bone marrow involvement in solid tumors -a retrospective observational study
Provisionally accepted- 1 Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, China
- 2 Second Hospital of Anhui Medical University, Hefei, Anhui Province, China
Solid tumor patients with bone marrow involvement (BMI) typically have a poor prognosis. However, some patients still exhibit a relatively good prognosis following aggressive treatment. This observation study aimed to identify prognostic factors to stratify patients and screen those who may benefit from aggressive treatment. It is found that solid tumor patients with BMI can benefit from aggressive anti-tumor treatments. Additionally, early diagnosis of BMI in solid tumor patients, selection of patients with a potential good prognosis, and administering appropriate anti-tumor treatments are key factors in prolonging the survival time of BMI patients.
Keywords: Formal analysis, investigation, Writing -review & editing. Bicheng Zhang: Data curation, Writing -original draft. Jing Xu: Software, Writing -review & editing. Lan Jin: Data curation, resources, Writingreview & editing. Jingjing Li: Software, visualization
Received: 18 May 2024; Accepted: 21 Oct 2024.
Copyright: © 2024 Zhang, Jin, Wu, Xu, Guo, Li and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Ting Zhang, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310009, Zhejiang Province, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.